Overview
Nature's Sunshine Q2 net sales up 4% to $114.8 mln, meeting expectations per LSEG data
GAAP net income rises to $5.3 mln, $0.28/share, from $1.3 mln, $0.07/share
Adjusted EBITDA increases 8% to $11.3 mln, driven by higher sales
Outlook
Natures Sunshine expects full-year 2025 net sales of $460 mln to $475 mln
Co expects FY25 adjusted EBITDA to range between $41 mln - $45 mln
Company confident in sustainable growth despite uncertain macroeconomic environment
Result Drivers
JAPAN AND EUROPE - Strong sales performance in Japan and Central Europe contributed to revenue growth, per CEO Terrence Moorehead
DIGITAL AND AUTO SHIP - Continued momentum in digital business and auto ship program supported sales increase
COST SAVINGS - Gross profit margin improvement driven by cost savings initiatives, despite unfavorable foreign exchange impacts
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Sales
Meet
$114.80 mln
$114.80 mln (2 Analysts)
Q2 Net Income
$5.30 mln
Q2 Adjusted EBITDA
$11.30 mln
Q2 Gross Margin
71.7%
Q2 Operating Income
$4.30 mln
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the food processing peer group is "buy"
Wall Street's median 12-month price target for Nature's Sunshine Products Inc is $20.50, about 29.7% above its July 30 closing price of $14.41
The stock recently traded at 18 times the next 12-month earnings vs. a P/E of 16 three months ago
Press Release: ID:nGNX4skb8G
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)